98%
921
2 minutes
20
Financial incentives have been used extensively in low-income and middle-income countries (LMICs) to improve health and service coverage. Little is known about their effectiveness in improving hypertension outcomes. We conducted a narrative literature review to document features of select supply-side (pay-for-performance, capitation) and demand-side [conditional cash transfers (CCT), vouchers] financing interventions focused on improving hypertension outcomes in primary care settings. Our review confirmed the paucity of studies, especially from LMICs. Pay-for-performance and capitation had small effects on screening, prescription practices, and blood pressure (BP) control. CCTs had mixed effects on screening and modest effects on BP control. Information on causal pathways, unintended consequences, and the use of vouchers was sparse. We then developed a conceptual model identifying pathways through which financing interventions influence hypertension outcomes. Based on this model, simulations in the context of Bangladesh indicated that pay-for-performance demands substantial financial resources but could become more favorable with increased treatment coverage.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/HJH.0000000000004021 | DOI Listing |
Int J Technol Assess Health Care
September 2025
Evidence Synthesis Group, Population Health Sciences Institute, Faculty of Medical Sciences, https://ror.org/01kj2bm70Newcastle University, Newcastle upon Tyne, UK.
Objectives: The National Institute for Health and Care Excellence (NICE) in England introduced early value assessments (EVAs) as an evidence-based method of accelerating access to promising health technologies that could address unmet needs and contribute to the National Health Service's Long Term Plan. However, there are currently no published works considering differences and commonalities in methods used between Assessment Reports for EVAs.
Methods: This rapid scoping review included all completed EVAs published on the NICE website up to 23 July 2024.
Hematology
December 2025
Thalassaemia International Federation (TIF), Nicosia, Cyprus.
Objective: The complexity of β-thalassaemia with associated morbidity, lifelong daily expensive treatment, and multidisciplinary care results in a considerable disease burden. Our study aimed to revisit the β-thalassaemia burden using epidemiological, clinical, and financial indicators related to patients, families, and healthcare systems.
Methods: Patient density measures, transfusion indices, complication rates, universal health coverage, and other indicators were tabulated by country and region.
Cancer
September 2025
Department of Biostatistics, Brown University School of Public Health, Providence, Rhode Island, USA.
Background: Opioid exposure during cancer therapy may increase long-term unsafe opioid prescribing. This study sought to determine the rates of coprescription of benzodiazepine and opioid medications and new persistent opioid use after surgical treatment of early-stage cancer.
Methods: A retrospective cohort study was conducted among a US veteran population via the Veterans Affairs Corporate Data Warehouse database.
Catheter Cardiovasc Interv
September 2025
California Medical Innovations Institute, San Diego, California, USA.
Background: We report the first in-literature animal experiment to validate the intracoronary ECG signal acquired from a coronary wire compared with the direct signal from an epicardial electrode.
Methods: An animal model study was performed in a 40 kg pig. Acute myocardial ischemia was induced by intracoronary balloon inflation for 60 s.